Predicting vaccination using numerical and affective risk perceptions: The case of A/H1N1 influenza

Vaccine

Volumn 30, Issue 49, 2012, Pages 7019-7026

  Renner, Britta ^a   Reuter, Tabea ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

A H1N1; Affect; Risk perception; Vaccination; Worry

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG UPTAKE; FEMALE; HEALTH PROGRAM; HUMAN; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GERMANY; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; VACCINATION; YOUNG ADULT;

EID: 84869089069     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.09.064     Document Type: Article

References (49)

1. World Health Organization. World now at the start of 2009 influenza pandemic. Available from: [online 2009, cited 07.10.12]. http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html.
2. Lau J.T.F., Yeung N.C.Y., Choi K.C., Cheng M.Y.M., Tsui H.Y., Griffiths S. Factors in association with acceptability of A/H1N1 vaccination during the influenza A/H1N1 pandemic phase in the Hong Kong general population. Vaccine 2010, 28:4632-4637. 10.1016/j.vaccine.2010.04.076.
3. Wichmann O., Stocker P., Poggensee G., Altmann D., Walter D., Hellenbrand W., et al. Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. Euro Surveill 2010, 15(May (18)). PII: 19561.
4. Wilking H., Buda S., von der Lippe E., Altmann D., Krause G., Eckmanns T., et al. Mortality of 2009 pandemic influenza A(H1N1) in Germany. Euro Surveill 2010, 15(December (49)). PII: 19741.
5. Nichol K.L. Efficacy and effectiveness of influenza vaccination. Vaccine 2008, 26(Suppl. 4):D17-D22.
6. Walter D., Böhmer M., van der Heiden M., Reiter S., Krause G., Wichmann O. Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10 - results from thirteen consecutive cross-sectional surveys. Vaccine 2011, 23:4008-4012. 10.1016/j.vaccine.2011.03.069.
7. Renner B., Schupp H. The perception of health risks. The Oxford handbook of health psychology 2011, 639-667. Oxford University Press, New York. H.S. Friedman (Ed.).
8. Weinstein N.D. Exploring the links between risk perceptions and preventive health behavior. Social psychological foundations of health and illness 2003, 22-53. Blackwell, Oxford. J. Suls, K.A. Wallston (Eds.).
9. Slovic P. The perception of risk 2000, Earthscan Publications, London.
10. Brewer N.T., Chapman G.B., Gibbons F.X., Gerrard M., McCaul K.D., Weinstein N.D. Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. Health Psychol 2007, 26(2):136-145. 10.1037/0278-6133.26.2.136.
11. Liao Q., Cowling B.J., Lam W.W.T., Fielding R. Factors affecting intention to receive and self-reported receipt of 2009 pandemic (H1N1) vaccine in Hong Kong: a longitudinal study. PLoS One 2011, 6(3):e17713. 10.1371/journal.pone.0017713.
12. Slovic P., Peters E. Risk perception and affect. Curr Dir Psychol Sci 2006, 15(6):322-325. 10.1111/j. 1467-8721.2006.00461.x.
13. Schmälzle R., Schupp H.T., Barth A., Renner B. Implicit and explicit processes in risk perception: neural antecedents of perceived HIV risk. Front Hum Neurosci 2011, 5:43. 10.3389/fnhum.2011.00043.
14. Renner B., Schmälzle R., Schupp H.T. First impressions of HIV risk: it takes only milliseconds to scan a stranger. PLoS One 2012, 7(1):e30460. 10.1371/journal.pone.0030460.
15. Loewenstein G.F., Weber E.U., Hsee C.K., Welch E. Risk as feelings. Psychol Bull 2001, 127:267-286. 10.1037/0033-2909-127-2.267.
16. Chapman G.B., Coups E.J. Emotional and preventive health behavior: worry, regret, and influenza vaccination. Health Psychol 2006, 25:82-90. 10.1037/0278-6133.25.1.82.
17. Liao Q., Cowling B.J., Lam W.W.T., Fielding R. The influence of social-cognitive factors on personal hygiene practices to protect against influenzas: using modelling to compare Avian A/H5N1 and 2009 Pandemic A/H1N1 influenzas in Hong Kong. Int J Behav Med 2010, 10.1007/s12529-010-9123-8.
18. Liao Q., Cowling B., Lam W.T., Ng M.W., Fielding R. Situational awareness and health protective responses to pandemic influenza A (H1N1) in Hong Kong: a cross-sectional study. PLoS One 2010, 5(10):e13350. 10.1371/journal.pone.0013350.
19. Brown S.L. Relationships between risk-taking behavior and subsequent risk perceptions. Br J Psychol 2005, 96:155-164. 10.1348/000712605X36703.
20. Renner B., Schüz B., Sniehotta F.F. Preventive health behavior and adaptive accuracy of risk perceptions. Risk Anal 2008, 28:741-748. 10.1111/j. 1539-6924.2008.01047.x.
21. Alkuwari M.G., Selim N.A., Nazzal Z.A.S., Al-Nuaimi S.A. Pandemic influenza A/H1N1 vaccination uptake among health care workers in Qatar: motivators and barriers. Vaccine 2011, 29:2206-2211. 10.1016/j.vaccine.2010.08.093.
22. Gaygisiz U., Gaygisiz E., Ozkan T., Lajunen T. Why were Turks unwilling to accept the A/H1N1 influenza-pandemic vaccination? People's beliefs and perceptions about the swine flu outbreak and vaccine in the later stage of the epidemic. Vaccine 2010, 29:329-333. 10.1016/j.vaccine.2010.10.030.
23. Kwon Y., Cho H.-Y., Lee Y.-K., Bae G.-R., Lee S.-G. Relationship between intention of novel influenza A (H1N1) vaccination and vaccination coverage rate. Vaccine 2011, 29:161-165. 10.1016/j.vaccine.2010.10.063.
24. Reuter T., Renner B. Who takes precautionary action in the face of the new H1N1 influenza? Prediction of who collects a free hand sanitizer using a health behavior model. PLoS One 2011, 6(7):e22130. 10.1371/journal.pone.0022130.
25. Jones J.H., Salathé M. Early assessment of anxiety and behavioral response to novel swine-origin influenza A (H1N1). PLoS One 2009, 4(12):e8032. 10.1371/journal.pone.0008032.
26. Cameron L.D., Sherman K.A., Marteau T.M., Brown P.M. Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychol 2009, 28:307-316. 10.1037/a0013947.
27. Van D., McLaws M.L., Crimmins J., MacIntyre C.R., Seale H. University life and pandemic influenza: attitudes and intended behaviour of staff and students towards pandemic (H1N1) 2009. BMC Public Health 2010, 10:130-138. http://www.biomedcentral.com/1471-2458/10/130.
28. Das Statistische Bundesamt. Zahlen und Fakten. Available at [cited 20.03.12]. https://www.destatis.de/DE/ZahlenFakten/ZahlenFakten.html.
29. Croyle R.T., Sande G.N. Denial and confirmatory search: paradoxical consequences of medical diagnosis. J Appl Soc Psychol 1988, 18:473-490. 10.1111/j.1559-1816.1988.tb00030.x.
30. Cohen J. A power primer. Psychol Bull 1992, 112:155-159.
31. Arbuckle J.L. Full information estimation in the presence of incomplete data. Advanced structural equation modeling 1996, 243-277. Erlbaum, Mahwah. G.A. Marcoulides, R.E. Schumacker (Eds.).
32. Preacher K.J., Hayes A.F. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008, 40:879-891. 10.3758/BRM.40.3.879.
33. Hayes A.F., Beyond Baron, Kenny Statistical mediation analysis in the new millennium. Commun Monogr 2009, 76:408-420. 10.1080/03637750903310360.
34. Mathieu J.E., Taylor S.R. Clarifying conditions and decision points for meditational type inferences in organizational behavior. J Organ Behav 2006, 27:1031-1056.
35. Aiken L.S., West S.G. Multiple regression: testing and interpreting interactions 1991, Sage, Thousand Oaks.
36. The Gallup Organization. Influenza H1N1 analytical report. Flash Eurobarometer. Available from: [March 2009; cited 07.10.12]. http://ec.europa.eu/public_opinion/flash/fl_258_en.pdf.
37. Ditto P.H., Pizarro D.A., Epstein E.B., Jacobson J.A., MacDonald T.K. Visceral influences on risk-taking behavior. J Behav Decis Making 2006, 19:99-113. 10.1002/bdm.520.
38. Van Gelder J.L., De Vries R.E., Van der Pligt J. Evaluating a dual-process model of risk: affect and cognition as determinants of risky choice. J Behav Decis Making 2009, 22:45-61. 10.1002/bdm.610.
39. Rubin G.J., Potts H.W.W., Michie S. Likely uptake of swine and seasonal flu vaccines among healthcare workers. A cross-sectional analysis of UK telephone survey data. Vaccine 2011, 29:2421-2428. 10.1016/j.vaccine.2011.01.035.
40. Harris A.J.L., Corner A., Hahn U. Estimating the probability of negative events. Cognition 2009, 110:51-64. 10.1016/j.cognition.2008.10.006.
41. European Commission (EC). A guideline on the readability of the label and package leaflet of medicinal products for human use. EC Pharmaceuticals Committee; 1998. Available from: [cited 07.10.12]. http://www.alims.gov.rs/download_eng/regulativa/gl981002.pdf.
42. Berry D.C., Raynor D.K., Knapp P., Bersellini E. Patients' understanding of risk associated with medication use. Drug Saf 2003, 26(1):1-11.
43. Baron J., Ritov I. Protected values and omission bias as deontological judgments. The psychology of learning and motivation 2009, vol. 50:133-167. Academic Press, San Diego, CA. D.M. Bartels, C.W. Bauman, L.J. Skitka, D.L. Medin (Eds.).
44. Brown K.F., Kroll J.S., Hudson M.J., Ramsay M., Green J., Vincent C.A., et al. Omission bias and vaccine rejection by parents of healthy children: implications for the influence A/H1N1 vaccination programme. Vaccine 2010, 28:4181-4185. 10.1016/j.vaccine.2010.04.012.
45. Moore T. In Germany, a better vaccine for politicians? TIME. Available from: [2009 October 27, cited 07.10.12]. http://www.time.com/time/health/article/0,8599,1932366,00.html.
46. Bild Merkel lässt sich impfen, Schäuble vermutlich nicht. Available from: [2009 October 19, cited 07.10.12]. http://www.bild.de/politik/2009/regierung/experten-werfen-regierung-zwei-klassen-medizin-vor-10142000.bild.html.
47. Robert Koch Institute. Neue Influenza: Ständige Impfkommission legt Impfempfehlungen vor. Available from: [online 2009, cited 07.10.12]. http://edoc.rki.de/documents/rki_pressemitteilungen/rewqSYz0K6UvY/PDF/29SnLt4bSVQW2.pdf.
48. Reyna V.F. Risk perception and communication in vaccination decisions: a fuzzy-trace theory approach. Spec Issue Vaccine - Int Vaccinat Risks: Vaccine 2012, 25:3790-3797. 10.1016/j.vaccine.2011.11.070.
49. Betsch C., Brewer N.T., Brocard P., Davies P., Gaissmaier W., Haase N., et al. Opportunities and challenges of web 2.0 for vaccination decisions. Spec Issue Vaccine - Int Vaccinat Risks: Vaccine 2012, 25:3727-3733. 10.1016/j.vaccine.2012.02.025.